companydata.dkcompanydata.dk

Fenucure Medical ApS: Financial statements 2020

CVR: 28486871

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

Fenucure Medical ApS (CVR 28486871) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -2,428,815 and a net result of DKK -3,181,263. Equity in the 2020 report amounted to DKK -976,366. The company had 2 employees in the financial year.

Gross Profit
DKK -2,428,815
Profit/Loss
DKK -3,181,263
Equity
DKK -976,366
Total Assets
DKK 4,083,156
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020--2.4M-3.2M-976K2
2018--608K-88K2.4M-
2017--1.6M-2.2M121K1
2016200K-1.7M-1.8M-3.2M-
20151.2M-723K-1.1M-1.3M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Fenucure Medical ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Niels Christian Beck Vase joins the board of Fenucure Medical ApSSep 14, 2020

As of September 14, 2020, Niels Christian Beck Vase has joined the board of directors of Fenucure Medical ApS.

Fenucure Medical ApS publishes interim reportMay 1, 2020

Fenucure Medical ApS has published its interim report for the period July 1, 2018 to December 31, 2019.

About Fenucure Medical ApS

Fenucure Medical ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2005. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named V-BIOTEK ApS and VIND INVEST ApS. The management consists of Christian Hother Sørensen. The board consists of Nicolai Fink Gundersen (chair), Alex Gundersen, Mogens Viktor Madsen and Niels Christian Beck Vase. The company is owned by V-BIOTEK HOLDING ApS, Redwood Foundation ApS and Alex Gundersen Assens ApS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -1,214,608 and a net result of DKK -3,201,378 compared with DKK -1,529,007 the year before. Equity in the 2025 report amounted to DKK 593,861.

Source: annual report 2025, Danish Business Authority